chrisvoncsefalvay/vaers-outcomes huggingface dataset:
really dizzy and felt like she could pass out; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (really dizzy and felt like she could pass out) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A, 023M20A and 013L20B) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (really dizzy and felt like she could pass out). At the time of the report, DIZZINESS (really dizzy and felt like she could pass out) outcome was unknown.            Patient is on Blood pressure medication.  The patient thought this is due to the low blood pressure condition that landed in the hospital.   First dose of the suspect product was administered on 27Jan2021 with batch number 013L20B Second dose of the suspect product was administered on 24Jan2021 with batch number 023M20A  No Treatment information was provided.   This case was linked to MOD-2021-413683 (Patient Link).
After receiving the shot the patient was fine but 2 minutes later she started shaking like having seizure. After it, she felt  dizzy, we gave some water and offer to call 911 but her parents refused. After couple of minutes she was feeling well.
parent reported that pt exp whelps, some swelling, & itching approx 2/4-5hr p/vax;
expired Moderna vaccine administered to patients; Vials were initially stored in the refrigerator on 05-Apr-2022 and then administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (Vials were initially stored in the refrigerator on 05-Apr-2022 and then administered) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (Vials were initially stored in the refrigerator on 05-Apr-2022 and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (Vials were initially stored in the refrigerator on 05-Apr-2022 and then administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Reportedly, 20 doses were initially stored in the refrigerator on 05-Apr-2022. Manufacturing date was reported as 01-Dec-2021.  Patients had not reported any adverse reactions.  Doses were administered after 30-day Use By Date or after manufacturer date of expiry. Vaccines were administered in between 06-Apr-2022 to 09-Apr-2022.  The vials did not undergo any temperature excursions.  Treatment details were not reported by the reporter.    .   This case was linked to MOD-2022-537580, MOD-2022-538675 (Patient Link).
High fever (104-105), Shaking and twitching for 48 hours (even when afebrile).
uticarial rash broke out all over body.  Fist Pfizer shot (all  3 previous doses had been Moderna)
Patient was found unresponsive on 11/05/2021. Was taken to Hospital, tested positive for Covid-19, and was admitted on 11/05/2021. She was released from hospital on 11/08/2021.
Fever 102 from 4 hours after vaccine with severe chills, severe bone and joint pain,dizziness, headache, nausea and vomiting and major fatigue from 4 hours after vaccine until Friday Feb 5th for 9 days.  I was in the bed so sick for 9 days could not even sit up in bed without being extremely sick.  Tylenol 1000mg every 8 hours for 9 days. Prescribed Phenergan 25mg and written out of work until 2/6 by physician due to vaccine reaction to first dose of pfeizer covid vaccine. Instructed to not take second dose or any subsequent dose of vaccine. And listed as adverse vaccine reaction in EMR. Was followed by Physician at clinic and health nurse. They also reported this vaccine reaction to hospital.
really bad pain in the arm; injection site pain; experiencing fatigue,; Armpit felt tender; Sever muscle ache,; chills; 100.1F fever; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (really bad pain in the arm), VACCINATION SITE PAIN (injection site pain), FATIGUE (experiencing fatigue,), AXILLARY PAIN (Armpit felt tender) and MYALGIA (Sever muscle ache,) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 061E21A, 024M20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (really bad pain in the arm), VACCINATION SITE PAIN (injection site pain), FATIGUE (experiencing fatigue,), AXILLARY PAIN (Armpit felt tender), MYALGIA (Sever muscle ache,), CHILLS (chills), PYREXIA (100.1F fever), HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (really bad pain in the arm), FATIGUE (experiencing fatigue,), AXILLARY PAIN (Armpit felt tender), MYALGIA (Sever muscle ache,), CHILLS (chills), PYREXIA (100.1F fever), HEADACHE (Headache) and NAUSEA (Nausea) had resolved and VACCINATION SITE PAIN (injection site pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.1 (High) 100.1 F.         This case was linked to MOD-2021-370969, MOD-2021-371023, MOD-2021-370853 (Patient Link).
First COVID symptoms appeared May 18 tested negative  Tested Positive May 20 twice with two different home testing kits and scheduled a telehealth  visit with my internet. Paxlovid was prescribed and begun on the 20th, symptoms of cough and fatigue subsided by the 24th and by the 26 symptoms were essentially gone with only an occasional cough.  No recurrence as of today 6/30/22.
About May 1, started excessive bruising from unknown sources.  Bruising takes about 3 weeks to clear up. Mostly on legs, arms, chest, shoulders.
Redness, swelling and extreme sensitivity to pain where shot was given. Went away about an hour after infant Tylenol was given. Also cool wash cloth was used on area.
pt recv vax 18JUL97 & 19JUL97 pt devel swelling, redness, & pain @ the inj site;pt recovered on 26JUL97;
I began having uterine bleeding a little over 2 weeks (6/17/2021) after the 2nd vaccine on 6/1/2021. First vaccine 5/11/2021. I am 69 years old. I have had regular menstrual bleeding every month since then. I have been in menopause since age 50. My doctors have done ultrasound and  labs. They found no reason for the bleeding.
Presented with SOB; dx 9/19 with Covid, already received monoclonal antibiody therapy day of dx; Admit 9/23 tele with Covid PNA on 3 LPM O2 (uses 2 LPM baseline at home); tx with 9/23 steroids, Vit c, Zinc started   9/24 Remdesivir, Actemra, Lovenox, Singulair started; O2 requirements: 2LPM baseline; admitted at 4 LPM in ED; up to 12 LPM by 9/24 (remdesivir started); slowly weaned back down to 4 LPM by 10/1
Information has been received from a nurse concerning a 11 year old female patient who on unspecified date was vaccinated with a second dose of VARIVAX (Merck) (route and lot number: 664719/0804Y).  The nurse reported that "the patient developed a very large area of swelling and pain at the injection site after the patient received the second dose of the vaccine".  At the time of the report the outcome of the patient was unknown.  The patient sought unspecified medical attention by phone call.  All telephone attempts to contact the reporter have been unsuccessful.  This is one of several reports received from the same source.  A standard lot check investigation has been finalized.  All in-process quality checks for the lot number 664719/0804Y were satisfactory.  The lot met the requirements of the Center for Biologics Evaluation and Research and was released.  No further information is available.
Systemic: Chills-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Mild
At 10:00 am - my first symptoms began with a headache.  Chills, fever (100.0),  muscle pains, joint pain, fatigue,
Cellulitis of (L) leg possible due to varicella vaccine administration. Started antibiotics 11/8/18.
Patient states he cannot lift his right arm on some days after receiving the Moderna vaccine.  He states he has to do physical therapy to help him recover
abdominal discomfort; 3 itchy bumps also appeared in the left breast area; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 01Feb2021 08:30 (Lot Number: EL9265) at single dose for COVID-19 immunization. Medical history included hypertension and irritable bowel syndrome (IBS), Shellfish allergy. Patient didn't have COVID prior vaccination. Concomitant medications included metoprolol succinate ER 25mg taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported. No other vaccines were administered in four weeks. After the shot on 01Feb2021, there was abdominal discomfort within 15 minutes. 3 itchy bumps also appeared in the left breast area. No treatment was received for the events. The outcome of the events was not recovered. COVID was not tested post vaccination.
Patient was very anxious prior to vaccination.  After injection, I inquired how the patient was feeling.  Patient stated she felt OK.  She remained seated and asked for water.  I walked to cooler to retrieve a cold bottled water and upon returning her mother was standing over her.  Patient then appeared to faint and then seize for 2-3 seconds and then came to and asked "What just happened?"  At that time the mother informed me that the patient had a history of prepubescent  seizures of which she thought she was over - last seizure happened around age 12.  Answered NO on the questionnaire Do you have a neurological disorder such as seizures?  Mother and I both remained by patient's side for additional 30 to 40 minutes assessing her physical and mental well being.  Patient continued to drink the water, ice pack applied to back of neck to help cool her which she asked for as well.  Patient was able to stand up and walk out of pharmacy unassisted.  Followed up with mother next day and mother stated patient felt a little dizzy in the morning but if feeling just fine as of 24 hours post immunization.
Narrative: Patient received first dose of Moderna COVID vaccine 03/10/2021 and second dose on 04/12/2021. No documented reactions until patient offered booster in 05/2022 in which patient declined booster and reported that he did not tolerate the vaccine due to "nights sweats". Time and date of "night sweats" not specified in chart.
losing her hair like if she was getting radiation; body weakness/hasn't energy; difficulty breathing; feels like a burning liquid was put inside of her like if she received gasoline and set up fire.; feels ancient; intense headaches; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (losing her hair like if she was getting radiation), ASTHENIA (body weakness/hasn't energy), DYSPNOEA (difficulty breathing), BURNING SENSATION (feels like a burning liquid was put inside of her like if she received gasoline and set up fire.) and VACCINATION COMPLICATION (feels ancient) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Multiple allergies.    On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (losing her hair like if she was getting radiation), ASTHENIA (body weakness/hasn't energy), DYSPNOEA (difficulty breathing), BURNING SENSATION (feels like a burning liquid was put inside of her like if she received gasoline and set up fire.), VACCINATION COMPLICATION (feels ancient) and HEADACHE (intense headaches). At the time of the report, ALOPECIA (losing her hair like if she was getting radiation), ASTHENIA (body weakness/hasn't energy), DYSPNOEA (difficulty breathing), BURNING SENSATION (feels like a burning liquid was put inside of her like if she received gasoline and set up fire.), VACCINATION COMPLICATION (feels ancient) and HEADACHE (intense headaches) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-074683 (Patient Link).
SOME ACHINESS; FELT A LITTLE TIRED; This spontaneous report received from a patient concerned a 67 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 07-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced some achiness, and felt a little tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from some achiness, and felt a little tired. This report was non-serious. This case, involving the same patient is linked to 20211223299. This case, from the same reporter is linked to 20211223201.
Tempt 102.1 chills  terrible headache felt like me brain was on fire  dizzy  no appetite  sick to my stomach & pain dry mouth
This is a 17 Months   old Female with a history of extreme prematurity and TBI, developmental delay and seizure disorder brought in by mother presenting with [a single seizure] that occurred [just prior to arrival]  Patient [has a history  ] of previous seizures.  Patient's first clinical diagnosis of seizure was on 5/21/2022.  This is the patient's second seizure since that time.  At the time of the seizure, the patient did have a subjective fever.  Per mother, the patient was given Tylenol once the fever was noted, and the fever went down.  At home, patient takes 1 mL (100 mg) Keppra twice daily (at 9 AM and 9 PM).  Patient's dosage of Keppra was increased from 0.8 mL to 1 mL 5 days ago.    2 weeks ago, the patient tested positive for COVID-19.  The patient's symptoms of COVID-19 have since resolved.  The patient received their first dose of the COVID-19 vaccination yesterday.
pain at injection site; This is a spontaneous report from a contactable consumer (Patient) reported for herself. A 55-Year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), via an unspecified route of administration in left arm on 04Mar2021 at 09:15 (Lot number: EL3247), (at the age of 55-years-old) as first dose, single for COVID-19 immunization. The patient medical history was not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. No known allergies reported. Concomitant medications included ciclosporin (RESTASIS), estradiol, multivitamins, omega 3. The patient did not receive any vaccines within four weeks prior to the vaccination. On 04Mar2021, the patient experienced pain at injection site. The patient did not receive any treatment for the event. Outcome of the event was recovered on an unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.
7/24/2022 - headache, nausea, diarrhea, weakness, fatigue, severe left knee pain, and flu-like symptoms.
I didn't notice anything  other than the kind of pain I get after a flu shot.  On Wednesday, a week after the shot,  the area on my arm began itching and I noticed a red 2" circle around the injection site.  Today, Friday, it has grown to 4". It is sore to the touch.
Shingles rash; Shingles rash; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 85-year-old male patient who received Herpes zoster (Shingrix) (batch number 53RF3, expiry date 17th October 2021) for prophylaxis.   On 12th July 2019, the patient received the 1st dose of Shingrix. On 11th August 2019, 30 days after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional case details were reported as follows: The patient developed shingles rash approximately two days ago from day of reporting. The reporter gave permission to follow up.
Initial and follow up information has been received from a registered nurse concerning an 82 year old male patient with codeine allergy, DEMEROL allergy, morphine allergy, SEPTRA allergy, FLOXIN allergy and THORAZINE allergy, hypertension, diabetes, neuropathy peripheral and reactive airways disease and a history of chickenpox in his 50's who on 09-APR-2010 was vaccinated subcutaneously with a 0.65ml dose of ZOSTAVAX (Merck) (lot# 664636/0874Y) into his right arm. Concomitant therapy included DYAZIDE, NEURONTIN, finasteride (manufacturer unknown), DUONEB and cyanocobalamin. On 22-JUN-2010 the patient developed shingles. The patient had lesions presented on right 12th dermatome region. The patient reported his pain to be 9 to 10 on a scale of 1 to 10. The patient also had back pain and discomfort. It was reported that the patient had no exposure to chickenpox or shingles. No rash occurred at the injection site or elsewhere within 42 days of the vaccination. No direct fluorescent antibody was done and no photos had been taken. The patient visited the office. On 24-JUN-2010, the patient was started on antiviral medications. Urine test was performed with normal result. At the time of this report, the patient's shingles persisted. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present, to identify if it is associated with the wild type (WT) VZV strain or with the Merck vaccine strain. A lesion sample was collected on 28-JUN-2010. The sample was taken from vesicle. On 28-JUN-2010 the sample was sent to the laboratory. Follow up information has been received from the nurse who reported that the patient had an appointment with the physician because he still had lesions. Follow up information has been received which reported the VZV final result was wild type strain. Follow up information has been received from the registered nurse concerning the 82 year old retired male patient who on 09-APR-2010 was vaccinated subcutaneously with the first dose of ZOSTAVAX (Merck) (lot# 664636/0874Y) into his right arm. On 22-JUN-2010, the patient developed shingles post receiving vaccine. On 06-JUL-2010, the patient recovered from shingles. Additional follow up information has been received which reported that on 28-JUN-2010, three vesicle lesion samples were collected and on the same day the samples were sent to the laboratory. On 29-JUN-2010 the sample arrived in laboratory. VZV DNA and B globin were amplified and the VZV strain identification showed adequate specimen which identified the presence of wild type strain. Follow up information has been received from the registered nurse concerning the 82 year old retired male patient who on 09-APR-2010 was vaccinated subcutaneously with the first dose of ZOSTAVAX (Merck) (lot# 664636/0874Y) into his right arm. There was no illness at time of vaccination. On 24-JUN-2010, the patient developed shingles post receiving vaccine. On 06-JUL-2010, the patient recovered from shingles. Additional information is not expected.
sinus; slight nasal congestion; coughing; fever; positive for covid-19; mildly sore arm; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (positive for covid-19), SINUSITIS (sinus), COUGH (coughing), PYREXIA (fever) and HEADACHE (headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Overweight.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (headache). On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (mildly sore arm). On 03-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (positive for covid-19). On an unknown date, the patient experienced SINUSITIS (sinus), COUGH (coughing), PYREXIA (fever) and NASAL CONGESTION (slight nasal congestion). On 12-Mar-2021, PAIN IN EXTREMITY (mildly sore arm) had resolved. On 13-Mar-2021, HEADACHE (headache) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (positive for covid-19), SINUSITIS (sinus), COUGH (coughing), PYREXIA (fever) and NASAL CONGESTION (slight nasal congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. Patient reported taking antibiotics (Azithromycin), and acetaminophen (Tylenol).
Information has been received from a health professional concerning an 8 year old white female with allergies to Amoxil and Cefzil and no other pertinent medical history who on 5/10/096 was vaccinated SC in the left arm with a first dose of varicella virus vaccine live (lot # 608585/0390B). Concomitant medication included a first dose of SC in the right arm of MMR (lot # 613240/1414B). There was no illness at the time of vaccination. On approximately 3/16/04 the patient developed chicken pox. It was reported that she had 18-25 lesions located on the chest, legs, and arms. Unspecified medical attention was sought. No product quality complaint was involved. No additional information was provided. Follow up information from the health care professional indicated that the patient's chicken pox started on 3/17/04. It was described as 18-25 insect bite like lesions on the chest/UE/LE, lasting for 5-7 days. There were no labs or diagnostic tests done. It was reported that the patent recovered. Additional follow up indicated that the patient had 18-25 maculo papular lesions on the chest and extremities that began on 3/17/04. At the office visit she had a temperature of 100.6. It was also reported that the child had exposure to varicella during the prior week. Additional information is not expected.